Spyre Therapeutics, Inc. (NASDAQ:SYRE) Cap table

Spyre Therapeutics, Inc.

Cap table

Built by 6ix from Spyre Therapeutics, Inc.’s releases · as of Nov 3, 2026

Common shares
94,969,184
Fully diluted
94,983,517

Fully diluted

LineSharesAs of
Common shares94,969,184Oct 27, 2026
Options and RSUs14,333Nov 2, 2026

Warrants and options

Lot
Stock options · US$95.51 · expire about Nov 2036
RSUs · expiry not stated

Share count over time

CountShares
Oct 27, 202694,969,184